CLOSE
MENU
A female doctor explains a procedure to a patient
A female doctor explains a procedure to a patient

Allergy

Explore our product portfolio.

.5 ml bottle of Bausch + Lomb Alrex® Opthalmic Suspension 0.2%
.5 ml bottle of Bausch + Lomb Alrex® Opthalmic Suspension 0.2%

ALREX®

(loteprednol etabonate ophthalmic suspension) 0.2%

5 ml botttle of Bausch + Lomb BEPREVE® Opthalmic Solution 1.5%
5 ml botttle of Bausch + Lomb BEPREVE® Opthalmic Solution 1.5%

BEPREVE®

(bepotastine besilate ophthalmic solution) 1.5%

ALREX®

IMPORTANT SAFETY INFORMATION

  • Do not use ALREX® if you have certain viral, bacterial or fungal diseases of the eye.
  • Do not use ALREX® if you are allergic to any of its ingredients or to other medications known as corticosteroids.
  • Use of ALREX® for a long time is associated with several significant side effects including glaucoma with damage to the eye’s optic nerve, vision defects, cataract formation, eye infections (including fungal and viral infections), and delay in wound healing.
  • If you use ALREX® for longer than 10 days, your doctor should monitor pressure in your eye.
  • Do not touch the dropper tip to any surface.
  • Do not wear a contact lens if your eye is red.
  • ALREX® should not be used to treat contact lens-related irritation.
  • Remove contact lenses prior to using ALREX®. The preservative in ALREX® may be absorbed by soft contact lenses. Lenses may be reinserted after 10 minutes.
  • In clinical studies, the most common side effects (occurring in 5-15% of patients) affecting the eye included abnormal vision/blurring, burning when placing drops on the eye, swelling of conjunctiva (clear membrane coating inner eyelid and outer surface of eye), eye discharge, dry eyes, excessive tearing, foreign body sensation, itching, eye redness, and light sensitivity. The most common side effects not affecting the eye (occurring in less than 15% of patients) included headache, runny nose, and sore throat.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click here for full Prescribing Information for ALREX®.

BEPREVE®
IMPORTANT SAFETY INFORMATION

  • Do not use BEPREVE® if you are allergic to its active ingredient (bepotastine besilate) or to any of the other ingredients.
  • Do not touch the dropper tip to any surface since this may contaminate the solution. Keep the bottle tightly closed when not in use.
  • Do not wear a contact lens if your eye is red.
  • BEPREVE® should not be used to treat contact-lens irritation.
  • Remove contact lenses before using BEPREVE®. Contact lenses can be reinserted 10 minutes after BEPREVE® is placed on the eye.
  • In clinical studies, the most common side effect, occurring in approximately 25% of subjects, was mild taste after use of the drops. Other side effects occurring in 2-5% of patients were eye irritation, headache, and allergic inflammation of the nose and throat.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click here for full Prescribing Information for BEPREVE®.

MTB.0215.USA.21